Keyword Pages
artificial intelligence 491
axial spondyloarthritis 491
future directions 491
imaging 491
innate immunity. 491
clinical manifestations 512
magnetic resonance imaging 512
roland-morris disability questionnaire 512
screening 512, 549
spondylosis. 512
cartilage 521
chondroitin-sulfate 521
glucosamine-sulfate 521
knee osteoarthritis 521
s-adenosylmethionine. 521
limited 542
scleroderma 542
systemic. 542
biological agents 549
children 549, 602
interferon-gamma release assay 549
tuberculin skin test. 549
elastography 556
nerve 556
shear-wave 556
systemic sclerosis 556
tibial 556
ultrasound. 556
anti-inflammatory agents 566
asic3 566
plant extracts 566
rheumatoid arthritis 566
trpv1. 566
angiogenesis 579
hif 579
hypoxia 579
psoriatic arthritis 579
vascular endothelial growth factor. 579
knee 590
mobile health 590
osteoarthritis 590
overweight 590
rehabilitation. 590
flare 602
inactive disease 602
juvenile idiopathic arthritis 602
methotrexate. 602
academic publications 611
covid-19 611
pandemic 611
perspective 611
rheumatology. 611
carpal tunnel syndrome 620
elasticity 620
electrodiagnosis 620
elastosonography 620
functional assessment. 620
age at diagnosis 633
recurrence 633
refractory disease 633
steroid-dependent disease. 633
cytokines 642
immunomodulatory 642
lactobacillus delbrueckii 642
lactobacillus rhamnosus 642
systemic lupus erythematosus. 642